Security key
696389204
- Security type / class
- Equity / COM
- Total 13F shares
- 268,203
- Total 13F value
- $158,269
- Share change
- +118,272
- SEC-reported price per share
- $0.59
- Number of holders
- 14
- Value change
- +$70,558
- Number of buys
- 7
- Number of sells
- 2
Report period
Q4 2023
Institutions
14
Top holders
10
PALI full security history
Ownership snapshot
Full 13F holder table
PALISADE BIO, INC. SEC filings
PALISADE BIO, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of PALI - PALISADE BIO INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Yuma Regional Medical Center
Disclosed value leader
Yuma Regional Medical Center
Comparable rows
0/15
Latest evidence
21 Nov 2023
3/4/5
13F
Highest disclosed value: $925,331
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Yuma Regional Medical Center has the largest disclosed position value at $925.3K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Yuma Regional Medical Center's linked filing trail.
Disclosed position value
Top 5
Yuma Regional Medical Center
$925.3K
VANGUARD GROUP INC
$39.6K
Thomas Hallam
$29.4K
GEODE CAPITAL MANAGEMENT, LLC
$20K
STATE STREET CORP
$13.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Yuma Regional Medical Center |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$925,331
1,814,375 shares
|
— | 19 Aug 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$39,607
68,054 shares
|
— | 30 Sep 2023 |
| Thomas Hallam |
3/4/5
Chief Executive Officer, Director
|
—
mixed-class rows
|
$29,372
137,592 shares
mixed-class rows
|
— | 16 Aug 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$20,048
34,448 shares
|
— | 30 Sep 2023 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$13,073
22,463 shares
|
— | 30 Sep 2023 |
| Michael John Dawson |
3/4/5
Chief Medical Officer
|
—
denominator unverified
|
$7,650
15,000 shares
|
— | 29 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
14
Shares
268,203
Rows available
14
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
12
Q4 2023 holders
14
Holder diff
2
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|